Mass General Brigham Ventures

We are an early-stage venture capital firm founded in 2008 to advance new life science technologies emerging from Mass General Brigham, one of the United States’ most renowned health systems for medical research. Our mission is to bring more bench-to bedside innovations to market to dramatically expand our positive impact on the quality of healthcare worldwide. Our investment strategy We invest in next-generation life science companies based on intellectual property created within our own research community.  We seek strong co-investor syndicates to develop products across a range of categories including drugs, devices, diagnostics, and digital health.​ Initial investments are directed at the seed and Series A stages, where our participation attracts capital and talent into the most difficult-to-fund phase of company development. When we invest, we expect to support each portfolio company through its entire financing lifecycle. In addition to providing the necessary venture capital, we leverage our experience in starting and growing companies, our expertise in the medical industry, and our network of scientific and business talent to build great companies.